Search

Your search keyword '"Fang, Zhaoyuan"' showing total 243 results

Search Constraints

Start Over You searched for: Author "Fang, Zhaoyuan" Remove constraint Author: "Fang, Zhaoyuan" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
243 results on '"Fang, Zhaoyuan"'

Search Results

1. Analogy-Forming Transformers for Few-Shot 3D Parsing

2. TIDEE: Tidying Up Novel Rooms using Visuo-Semantic Commonsense Priors

3. Simple-BEV: What Really Matters for Multi-Sensor BEV Perception?

4. Particle Video Revisited: Tracking Through Occlusions Using Point Trajectories

6. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

7. Review of Iris Presentation Attack Detection Competitions

8. Move to See Better: Self-Improving Embodied Object Detection

9. Iris Liveness Detection Competition (LivDet-Iris) -- The 2020 Edition

10. Open Source Iris Recognition Hardware and Software with Presentation Attack Detection

11. Iris Presentation Attack Detection: Where Are We Now?

12. Robust Iris Presentation Attack Detection Fusing 2D and 3D Information

13. AlignNet: A Unifying Approach to Audio-Visual Alignment

14. Review of Iris Presentation Attack Detection Competitions

15. Iris Presentation Attack Detection Based on Photometric Stereo Features

17. Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.

18. ZFP57 dictates allelic expression switch of target imprinted genes

19. GSIR: Generalizable 3D Shape Interpretation and Reconstruction

29. A vitamin-C-derived DNA modification catalysed by an algal TET homologue

31. Figure S2 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

32. Data from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

33. Table S1 from In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma

34. Supplementary Figure Legend from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

35. Table S1 from Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

36. Supplementary Table 1 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

37. Supplementary Figure 2 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

38. Supplementary Figure 4 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

39. Supplementary Table 2 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

40. Supplementary Figure 1 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

41. Data from Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

42. Supplementary Table 3 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

43. Supplementary Data from Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

44. Supplementary Figure 3 from The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers

45. Data from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

46. Supplementary Figure Legends 1-12 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

47. Supplementary Figures 1-12 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

48. Supplementary Methods from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

49. Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

Catalog

Books, media, physical & digital resources